DaTSCAN (Ioflupane I 123 Injection) SPECT Imaging Demonstrates Impact On The Diagnosis Of Patients With Clinically Uncertain Dementia With Lewy Bodies

New data on physician's confidence in diagnosis following use of DaTSCAN presented at 2013 American Academy of Neurology Meeting GE Healthcare today presented the results of a randomized study analyzing the effect of DaTSCAN™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult patients with a diagnosis of possible dementia with Lewy bodies (DLB). The findings, presented at the 2013 American Academy of Neurology Meeting, reported use of DaTSCAN imaging significantly contributed to a change in diagnostic category and improved physician confidence in diagnosing these patients...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news